Zografos L, Wolin D, Andrews E, Calingaert B, Balabanova Y, Horvat-Brocker A, Tarenz C, Suzart-Woischnik K. Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries. Expert Opin Drug Saf. 2022 Mar;21(3):435-46. doi: 10.1080/14740338.2022.1998451
Dundas SJ, von Haefen RH, Mansfield C. Recreation costs of endangered species protection: evidence from Cape Hatteras National Seashore. Marine Resource Economics. 2018 Jan;33(1):1-25. doi: 10.1086/694752
Grieger KD, Sayes C, Hendron CO, Rothrock G, Mansfield C, Jayanty RKM, Ensor D. Finding the key to responsible nanomaterial development. Ehs Today: The Magazine For Environment, Health And Safety Leaders. 2013 Dec 6.
Lavonas EJ, Fries JF, Furst DE, Rothman KJ, Stergachis A, Vaida AJ, Zelterman D, Reynolds KM, Green JL, Dart RC. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf. 2012 Jan 1;11(1):33-44.
Myers KH, Parsons GR, Edwards PET. Measuring the recreational use value of migratory shorebirds on the Delaware Bay. Marine Resource Economics. 2010 Apr 23;25(3):247-64.